Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S.

Ann Intern Med. 1999 Sep 7;131(5):363-75. Review.

PMID:
10475890
[PubMed - indexed for MEDLINE]
2.

[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].

Sydow K, Böger RH.

Z Kardiol. 2001 Jan;90(1):1-11. Review. German.

PMID:
11220081
[PubMed - indexed for MEDLINE]
3.

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC.

Am J Epidemiol. 1996 May 1;143(9):845-59.

PMID:
8610698
[PubMed - indexed for MEDLINE]
Free Article
4.

Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults.

Shimakawa T, Nieto FJ, Malinow MR, Chambless LE, Schreiner PJ, Szklo M.

Ann Epidemiol. 1997 May;7(4):285-93.

PMID:
9177112
[PubMed - indexed for MEDLINE]
5.
6.

Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?

Spence JD.

Am J Cardiovasc Drugs. 2001;1(2):85-9. Review.

PMID:
14728038
[PubMed - indexed for MEDLINE]
7.

Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.

Henning BF, Zidek W, Riezler R, Graefe U, Tepel M.

Res Exp Med (Berl). 2001 Mar;200(3):155-68.

PMID:
11426667
[PubMed - indexed for MEDLINE]
8.

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.

Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.

Am J Kidney Dis. 1999 Oct;34(4):669-77.

PMID:
10516348
[PubMed - indexed for MEDLINE]
9.

Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.

Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM.

Clin Nephrol. 1998 Apr;49(4):232-5.

PMID:
9582553
[PubMed - indexed for MEDLINE]
10.

Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease.

Duell PB, Malinow MR.

Curr Opin Lipidol. 1997 Feb;8(1):28-34. Review.

PMID:
9127708
[PubMed - indexed for MEDLINE]
11.

Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?

Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B, Hannedouche TP.

Nephrol Dial Transplant. 1999 Aug;14(8):1934-42.

PMID:
10462274
[PubMed - indexed for MEDLINE]
Free Article
12.

Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.

Tan NC, Venketasubramanian N, Saw SM, Tjia HT.

Stroke. 2002 Aug;33(8):1956-62.

PMID:
12154245
[PubMed - indexed for MEDLINE]
Free Article
13.

Homocyst(e)ine, vitamins and genetic interactions in vascular disease.

Malinow MR.

Can J Cardiol. 1999 Apr;15 Suppl B:31B-34B.

PMID:
10350683
[PubMed - indexed for MEDLINE]
14.

B vitamins and homocysteine in cardiovascular disease and aging.

Wilcken DE, Wilcken B.

Ann N Y Acad Sci. 1998 Nov 20;854:361-70. Review.

PMID:
9928444
[PubMed - indexed for MEDLINE]
15.

Association between homocyst(e)ine levels and risk of vascular events.

Kaplan ED.

Drugs Today (Barc). 2003 Mar;39(3):175-92. Review.

PMID:
12730702
[PubMed - indexed for MEDLINE]
16.

Homocysteine as a novel risk factor for atherosclerosis.

Guthikonda S, Haynes WG.

Curr Opin Cardiol. 1999 Jul;14(4):283-91. Review.

PMID:
10448607
[PubMed - indexed for MEDLINE]
17.

Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?

Virdis A, Ghiadoni L, Salvetti G, Versari D, Taddei S, Salvett A.

J Nephrol. 2002 Jul-Aug;15(4):414-21. Review.

PMID:
12243373
[PubMed - indexed for MEDLINE]
18.

Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.

Lee YK, Kwon YJ, Yoon JW, Oh KS, Cha DR, Cho WY, Huh K, Pyo HJ, Kim HK.

J Korean Med Sci. 1999 Apr;14(2):193-8.

PMID:
10331567
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Potential clinical and economic effects of homocyst(e)ine lowering.

Nallamothu BK, Fendrick AM, Rubenfire M, Saint S, Bandekar RR, Omenn GS.

Arch Intern Med. 2000 Dec 11-25;160(22):3406-12.

PMID:
11112233
[PubMed - indexed for MEDLINE]
20.

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.

Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.

Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):286-90. Epub 2002 Feb 21.

PMID:
11981642
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk